Abstract No. 564 Treatment of right-sided primary colon cancer metastatic to liver in current clinical practice

Right-sided primary (RSP) metastatic colorectal cancer (mCRC) is a poor prognostic factor compared with left-sided primary (LSP) tumor. No overall survival (OS) benefit was seen with transarterial radioembolization (TARE) as a first line therapy in the SIRFLOX, FOXFIRE Global, and FOXFIRE studies. However, a metaanalysis demonstrated a survival advantage for RSP patients. Little data exists between RSP and LSP outcomes when TARE is used as second- or third-line therapy. This retrospective analysis offers preliminary data on the differences between RSP and LSP mCRC treated with TARE.

Source: Journal of Vascular and Interventional Radiology : JVIR - February 20, 2020 Category: Radiology Authors: J. Martin, C. Robinson, J. Ronald, A. Sag, P. Suhocki, C. Kim Tags: Scientific e-Poster Source Type: research